169 related articles for article (PubMed ID: 8789802)
1. Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host.
Poller W; Schneider-Rasp S; Liebert U; Merklein F; Thalheimer P; Haack A; Schwaab R; Schmitt C; Brackmann HH
Gene Ther; 1996 Jun; 3(6):521-30. PubMed ID: 8789802
[TBL] [Abstract][Full Text] [Related]
2. The constitutive expression of the immunomodulatory gp19k protein in E1-, E3- adenoviral vectors strongly reduces the host cytotoxic T cell response against the vector.
Lee MG; Abina MA; Haddada H; Perricaudet M
Gene Ther; 1995 Jun; 2(4):256-62. PubMed ID: 7552985
[TBL] [Abstract][Full Text] [Related]
3. Association of vaccinia virus-expressed adenovirus E3-19K glycoprotein with class I MHC and its effects on virulence in a murine pneumonia model.
Grunhaus A; Cho S; Horwitz MS
Virology; 1994 May; 200(2):535-46. PubMed ID: 8178441
[TBL] [Abstract][Full Text] [Related]
4. Early region 3-replacement adenovirus recombinants are less pathogenic in cotton rats and mice than early region 3-deleted viruses.
Berencsi K; Uri A; Valyi-Nagy T; Valyi-Nagy I; Meignier B; Peretz FV; Rando RF; Plotkin SA; Gönczöl E
Lab Invest; 1994 Sep; 71(3):350-8. PubMed ID: 7933985
[TBL] [Abstract][Full Text] [Related]
5. Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo.
Yang Y; Wilson JM
J Immunol; 1995 Sep; 155(5):2564-70. PubMed ID: 7650386
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice.
Smith TA; Mehaffey MG; Kayda DB; Saunders JM; Yei S; Trapnell BC; McClelland A; Kaleko M
Nat Genet; 1993 Dec; 5(4):397-402. PubMed ID: 8298650
[TBL] [Abstract][Full Text] [Related]
7. Primary myoblast-mediated gene transfer: persistent expression of human factor IX in mice.
Yao SN; Smith KJ; Kurachi K
Gene Ther; 1994 Mar; 1(2):99-107. PubMed ID: 7584074
[TBL] [Abstract][Full Text] [Related]
8. Lack of persistence of E1- recombinant adenoviral vectors containing a temperature-sensitive E2A mutation in immunocompetent mice and hemophilia B dogs.
Fang B; Wang H; Gordon G; Bellinger DA; Read MS; Brinkhous KM; Woo SL; Eisensmith RC
Gene Ther; 1996 Mar; 3(3):217-22. PubMed ID: 8646552
[TBL] [Abstract][Full Text] [Related]
9. Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains.
Barr D; Tubb J; Ferguson D; Scaria A; Lieber A; Wilson C; Perkins J; Kay MA
Gene Ther; 1995 Mar; 2(2):151-5. PubMed ID: 7719932
[TBL] [Abstract][Full Text] [Related]
10. Mouse anti-adenovirus cytotoxic T lymphocytes. Inhibition of lysis by E3 gp19K but not E3 14.7K.
Rawle FC; Tollefson AE; Wold WS; Gooding LR
J Immunol; 1989 Sep; 143(6):2031-7. PubMed ID: 2789254
[TBL] [Abstract][Full Text] [Related]
11. Foreign gene expression by human adenovirus type 5-based vectors studied using firefly luciferase and bacterial beta-galactosidase genes as reporters.
Mittal SK; Bett AJ; Prevec L; Graham FL
Virology; 1995 Jun; 210(1):226-30. PubMed ID: 7793076
[TBL] [Abstract][Full Text] [Related]
12. Expression of adenovirus E3/19K protein does not alter mouse MHC class I-restricted responses to vaccinia virus.
Cox JH; Buller RM; Bennink JR; Yewdell JW; Karupiah G
Virology; 1994 Nov; 204(2):558-62. PubMed ID: 7941322
[TBL] [Abstract][Full Text] [Related]
13. Successful expression of human factor IX following repeat administration of adenoviral vector in mice.
Walter J; You Q; Hagstrom JN; Sands M; High KA
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3056-61. PubMed ID: 8610167
[TBL] [Abstract][Full Text] [Related]
14. Direct gene transfer to the liver with herpes simplex virus type 1 vectors: transient production of physiologically relevant levels of circulating factor IX.
Miyanohara A; Johnson PA; Elam RL; Dai Y; Witztum JL; Verma IM; Friedmann T
New Biol; 1992 Mar; 4(3):238-46. PubMed ID: 1316145
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus region E3 proteins that prevent cytolysis by cytotoxic T cells and tumor necrosis factor.
Wold WS; Gooding LR
Mol Biol Med; 1989 Oct; 6(5):433-52. PubMed ID: 2533958
[TBL] [Abstract][Full Text] [Related]
16. Sequence and functional analysis of the human adenovirus type 7 E3-gp19K protein from 17 clinical isolates.
Hermiston TW; Hellwig R; Hierholzer JC; Wold WS
Virology; 1993 Dec; 197(2):593-600. PubMed ID: 8249282
[TBL] [Abstract][Full Text] [Related]
17. Expression of human factor IX cDNA in mice by implants of genetically modified skin fibroblasts from a hemophilia B patient.
Zhou JM; Dai YF; Qiu XF; Hou GY; Akira Y; Xue JL
Sci China B; 1993 Sep; 36(9):1082-92. PubMed ID: 8274202
[TBL] [Abstract][Full Text] [Related]
18. Resistance of human cells to the adenovirus E3 effect on class I MHC antigen expression. Implications for antiviral immunity.
Routes JM; Cook JL
J Immunol; 1990 Apr; 144(7):2763-70. PubMed ID: 2156934
[TBL] [Abstract][Full Text] [Related]
19. Complementation of a human adenovirus early region 4 deletion mutant in 293 cells using adenovirus-polylysine-DNA complexes.
Scaria A; Curiel DT; Kay MA
Gene Ther; 1995 Jun; 2(4):295-8. PubMed ID: 7552990
[TBL] [Abstract][Full Text] [Related]
20. High-level expression and characterization of a mouse-human chimeric CD4 antibody with therapeutic potential.
Looney JE; Knight DM; Arevalo-Moore M; Trinh H; Pak KY; Dalesandro MR; Rieber EP; Riethmuller G; Daddona PE; Ghrayeb J
Hum Antibodies Hybridomas; 1992 Oct; 3(4):191-200. PubMed ID: 1477300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
